New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has demonstrated that OGM provided reliable and robust analytical performance with high ...
Enhancer hijacking emerges as a major “missing driver” mechanism in LBCL/PCN, enabling detection of non-chimeric oncogene activation such as IGL::BCL2, IGH::CCND2, and MAFA/MAFB rearrangements.
Researchers, discouraged by mapping's drudgery, doubt that a 5-year plan to finish high-resolution image is now feasible. WASHINGTON--After three years of escalating expectations, rising financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results